Remdesivir for the Treatment of Covid-19 — Final Report

Beigel, John H., Tomashek, Kay M., Dodd, Lori E., Mehta, Aneesh K., Zingman, Barry S., Kalil, Andre C., Hohmann, Elizabeth, Chu, Helen Y., Luetkemeyer, Annie, Kline, Susan, Lopez de Castilla, Diego, Finberg, Robert W., Dierberg, Kerry, Tapson, Victor, Hsieh, Lanny, Patterson, Thomas F., Paredes, Roger, Sweeney, Daniel A., Short, William R., Touloumi, Giota, Lye, David Chien, Ohmagari, Norio, Oh, Myoung-don, Ruiz-Palacios, Guillermo M., Benfield, Thomas, Fätkenheuer, Gerd, Kortepeter, Mark G., Atmar, Robert L., Creech, C. Buddy, Lundgren, Jens, Babiker, Abdel G., Pett, Sarah, Neaton, James D., Burgess, Timothy H., Bonnett, Tyler, Green, Michelle, Makowski, Mat, Osinusi, Anu, Nayak, Seema, Lane, H. Clifford·2020·New England Journal of Medicine
DOI 10.1056/nejmoa2007764

Cited by (1,018)

Items 1,001–1,018 of 1,018

  1. Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor–Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials
    Self, Wesley H., Shotwell, Matthew S., Gibbs, Kevin W., de Wit, Marjolein, Files, D. Clark, Harkins, Michelle, Hudock, Kristin M., Merck, Lisa H., Moskowitz, Ari, Apodaca, Krystle D. et al. · 2023 · JAMA
  2. Untitled work
    Gheibi · 2021 · 10.4103/1995-7645.318304
  3. Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England
    Perez-Guzman, Pablo N., Knock, Edward, Imai, Natsuko, Rawson, Thomas, Santoni, Cosmo Nazzareno, Alcada, Joana, Whittles, Lilith K., Thekke Kanapram, Divya, Sonabend, Raphael, Gaythorpe, Katy A. M. et al. · 2023 · Nature Communications
  4. Predicting Potential SARS-COV-2 Drugs—In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking
    Karki, Nischal, Verma, Niraj, Trozzi, Francesco, Tao, Peng, Kraka, Elfi, Zoltowski, Brian · 2021 · International Journal of Molecular Sciences
  5. Neuromuscular Diseases Care in the Era of COVID-19
    Bertran Recasens, Bernat, Rubio, Miguel Angel · 2020 · Frontiers in Neurology
  6. Beyond the physical risk: Psychosocial impact and coping in healthcare professionals during the COVID‐19 pandemic.
    Fteropoulli, Theodora, Kalavana, Theano V., Yiallourou, Anneza, Karaiskakis, Marios, Koliou Mazeri, Maria, Vryonides, Stavros, Hadjioannou, Anna, Nikolopoulos, Georgios K. · 2025 · Journal of Clinical Nursing
  7. Ivermectin for preventing and treating COVID-19
    Popp, Maria, Stegemann, Miriam, Metzendorf, Maria-Inti, Kranke, Peter, Meybohm, Patrick, Skoetz, Nicole, Weibel, Stephanie · 2021 · Cochrane Database of Systematic Reviews
  8. Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
    Hayward, Gail, Yu, Ly-Mee, Little, Paul, Gbinigie, Oghenekome, Shanyinde, Milensu, Harris, Victoria, Dorward, Jienchi, Saville, Benjamin R., Berry, Nicholas, Evans, Philip H. et al. · 2024 · Journal of Infection
  9. Rapid generation of circulating and mucosal decoy ACE2 using mRNA nanotherapeutics for the potential treatment of SARS-CoV-2
    Kim, Jeonghwan, Mukherjee, Anindit, Nelson, Dylan, Jozic, Antony, Sahay, Gaurav · 2020
  10. Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2
    Biering, Scott B., Van Dis, Erik, Wehri, Eddie, Yamashiro, Livia H., Wrynla, Xammy Huu, Dugast-Darzacq, Claire, Graham, Thomas G. W., Stroumza, Julien R., Golovkine, Guillaume R., Roberts, Allison W. et al. · 2021 · ACS Infectious Diseases
  11. Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes
    Dobosh, Brian, Zandi, Keivan, Giraldo, Diego Moncada, Goh, Shu Ling, Musall, Kathryn, Aldeco, Milagros, LeCher, Julia, Giacalone, Vincent D., Yang, Junkai, Eddins, Devon J. et al. · 2022 · Cell Reports
  12. Large Language Model–Assisted Risk-of-Bias Assessment in Randomized Controlled Trials Using the Revised Risk-of-Bias Tool: Evaluation Study
    Huang, Jiajie, Lai, Honghao, Zhao, Weilong, Xia, Danni, Bai, Chunyang, Sun, Mingyao, Liu, Jianing, Liu, Jiayi, Pan, Bei, Tian, Jinhui et al. · 2025 · Journal of Medical Internet Research
  13. Beyond dexamethasone, emerging immuno‐thrombotic therapies for COVID‐19
    Jensen, Melanie Peta, George, Marc, Gilroy, Derek, Sofat, Reecha · 2021 · British Journal of Clinical Pharmacology
  14. Fighting COVID-19 with Artificial Intelligence
    Monteleone, Stefania, Kellici, Tahsin F., Southey, Michelle, Bodkin, Michael J., Heifetz, Alexander · 2022 · Methods in molecular biology
  15. Persistence of disparities among racially/ethnically marginalized groups in the coronavirus disease 2019 pandemic regardless of statewide shelter-in-place policies: an analysis from northern California
    Azar, Kristen M J, Lockhart, Stephen H, Shen, Zijun, Romanelli, Robert, Brown, Stephanie, Smits, Kelly, Pressman, Alice R · 2021 · American Journal of Epidemiology
  16. Use of Tox21 Screening Data to Evaluate the COVID-19 Drug Candidates for Their Potential Toxic Effects and Related Pathways
    Sakamuru, Srilatha, Huang, Ruili, Xia, Menghang · 2022 · Frontiers in Pharmacology
  17. Sex-Related Differences in the Pharmacological Response in SARS-CoV-2 Infection, Dyslipidemia, and Diabetes Mellitus: A Narrative Review
    Lombrea, Adelina, Romanescu, Mirabela, Jianu, Narcisa, Andor, Minodora, Suciu, Maria, Man, Dana Emilia, Danciu, Corina, Dehelean, Cristina Adriana, Buda, Valentina · 2023 · Pharmaceuticals
  18. Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence
    Benkő, Beáta-Mária, De Brito Parreirinha, Neuza Sofia, Sebe, István, Zelkó, Romána · 2026 · iScience